PlainRecalls

Blossom Pharmaceuticals

Compiled from official public sources by the publisher.

13 recalls on record · Latest: Dec 10, 2025

Subscribe to new Blossom Pharmaceuticals recalls (RSS)

Agency notice ledger

Federal filing book Blossom Pharmaceuticals LIGHT-BOOK · SINGLE-AGENCY

#1,156 of 14,151 · 13 notices · 0.012% archive

  • BOOK 13 notices
  • RANK #1,156 of 14,151
  • SHARE 0.012% archive
  • AGENCY FDA Drug (13)
  • CAT cosmetics
  • CATS 2 categories
  • LATEST Dec 10, 2025
  • PHOTO Access Scientific LLC

Nearest notice-volume peer: Access Scientific LLC (0 notice gap)

Blossom Pharmaceuticals accounts for about 0.012% of the 104,423-notice archive on 13 distinct filings — a mid share signal beside absolute volume. FDA · CPSC · USDA FSIS · NHTSA notice stamps for this firm. Read with this firm → · Dominant category → · Similar-volume firm →

Where Blossom Pharmaceuticals sits among 14,151 recalling firms

Blossom Pharmaceuticals ranks 1,156th of 14,151 tracked firms by distinct recall-event count. Archive size reflects filing volume, not inherent product danger.

Blossom Pharmaceuticals vs all firms by recall-notice count

Where this firm's archive sits among every tracked recalling manufacturer

13 1156th of 14151 higher than 12,927 of 14,151 firms

Firms, banded by distinct federal recall-event inventory

Each bar is a band; taller bars hold more firms. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source FDA · CPSC · USDA FSIS · NHTSA federal recall filings · 2026-09-14

Blossom Pharmaceuticals in the notice-volume neighbourhood

Distinct federal recall events among this firm and nearest nationwide peers

notices

What this shows Blossom Pharmaceuticals holds about 0.012% of archive notices alongside 13 distinct filings.

Source FDA · CPSC · USDA FSIS · NHTSA filings aggregated by PlainRecalls As of September 2026
FDA Drug Moderate Dec 10, 2025

Globe Zinc Oxide Ointment USP Zinc Oxide 20% Skin Protectant, Net Wt. 2 oz (56.7 g), Distributed by: Trifecta Pharmaceuticals USA 101 NE, Third Avenue, Suite 1500, Ft. Lauderdale, FL 33301, NDC 69396-086-02.
FDA Drug Moderate Dec 10, 2025

Nivagen Pharmaceuticals, Zinc Oxide Ointment USP, Zinc Oxide 20% Skin Protectant, Net Wt. 15 oz (425g), Made in India, Manufactured for: Nivagen Pharmaceuticals, Inc., Sacramento, CA 95827, USA, NDC 75834-170-15.
FDA Drug Moderate Dec 10, 2025

Dynashield Skin Protectant, Net Wt. 16 oz (453.6 g), Manufactured for: Dyrnarex Corporation, 10 Glenshaw Street, Orangeburg, NY 10962, USA, Made in India, NDC 67777-407-04.
FDA Drug Moderate Dec 10, 2025

Wecare Enema, 4.5 Fl Oz/133mL, Manufactured for: Dynarex Corporation, 11 Dynarex Corporation, MIddletown, NY 10941 USA, Made in India, NDC 67777-402-01.
FDA Drug Moderate Dec 10, 2025

Wecare Calasoothe, Net wt. 4 oz (113 g), Manufactured for: Dynarex Corporation, 10 Glenshaw Street, Orangeburg, NY 10962, NDC 67777-234-04.
FDA Drug Moderate Dec 10, 2025

Dynashield, 4 oz cream (113 g), Manufactured for: Dynarex Corporation, 10 Glenshaw Street, Orangeburg, NY 10852, USA, Made in India, NDC 67777-407-03.
FDA Drug Moderate Dec 10, 2025

Nivagen, Zinc Oxide Ointment USP, Zinc Oxide 20 %, Net Wt. 1 oz. (28.4g), Nivagen Pharmaceuticals, Inc., Sacramento, CA 95827, USA, Made in India, NDC 75834-170-02.
FDA Drug Moderate Dec 10, 2025

Globe Clotrimazole Cream, USP, 1 %, Net Wt. 1 oz (28.4g), Distributed by: Trifecta Pharmaceuticals USA, 101 NE Third Avenue, Suite 1500, Ft. Lauderdale, FL 33301 USA, Made in India, NDC 69396-087-01.
FDA Drug Moderate Dec 10, 2025

Lanashield Skin Barrier, 4 oz. (113 g), Manfuactured for: Dynarex Corporation, 10 Gleshaw Street, Orangeburg, NY 10962 USA, Made in India, UPC 616784126319.
FDA Drug Moderate Dec 10, 2025

Nivagen, Zinc Oxide Ointment, Net Wt. 1 oz. (28.4g), Nivagen Pharmaceuticals, Inc., Sacramento, CA 95827, USA Made in India, NDC 75834-170-01.
FDA Drug Moderate Dec 10, 2025

Globe Clotrimazole Cream USP, 1 % Antifungal Cream, Net Wt., 5 oz. (142 g, Distributed by: Trifecta Pharmaceuticals USA, 101 NE Third Avenue, Suite 1500, Ft. Lauderdale, FL 33301, USA, NDC 69396-087-55.
FDA Drug Moderate Dec 10, 2025

Dynagel, Moisturizing Wound Hydrogel, Net Wt. 3oz (84.7 g), Manufactured for: Dynarex Corporation, 16 Glenshaw Street, Orangeburg, NY 10962, UPC 61784128016.
FDA Drug Moderate Dec 10, 2025

WeCare, Zinc Oxide Ointment, Net Wt. 15 oz/425 g, Manuactured for: Dynarex Corporation, 11 Dynarex Drive, Middletown, NY 10941, Made in India, NDC 67777-223-05.

Blossom Pharmaceuticals holds a measurable archive slice

Drug and device firms outside this manufacturer and state, matched by notice volume and category footprint.

Similar recall count

Nearest multi-notice firms by distinct-event totals (13 here — thin-book).

Access Scientific LLC 13 Acclarent, Inc. 13 Advanced Bionics, LLC 13 Aequita Pharmacy 13 Alden Optical 13

Similar cosmetics volume

Nearest multi-notice firms that share this firm's dominant product category.

Williams West & Witt's Products Company 13 Ca Botana International, Inc. 14 Tropicale Foods, LLC 14 Gfa Production Xiamen Co. Ltd. 10

Frequently Asked Questions

How many federal recall notices name Blossom Pharmaceuticals? ▼
PlainRecalls indexes 13 distinct federal recall events naming Blossom Pharmaceuticals, aggregated from FDA, CPSC, USDA FSIS, and NHTSA filings (archive as of September 2026). That count is an issuance inventory, not a hazard score.
Where does Blossom Pharmaceuticals sit among other recalling firms? ▼
Blossom Pharmaceuticals ranks #1,156 of 14,151 by distinct recall-event count among 14,151 firms in this archive (91st percentile of firms with fewer notices). Rank tracks filing frequency, not product danger.
Which agency issues most of Blossom Pharmaceuticals's notices? ▼
FDA Drug accounts for 13 of this firm's 13 indexed notices.
What product category dominates Blossom Pharmaceuticals's filing book? ▼
Filings for Blossom Pharmaceuticals span 2 product categories, led by cosmetics. Browse that category archive for peer firms and related notices.
Is a higher notice count more dangerous? ▼
No. Archive size reflects how often federal agencies publish recalls naming the firm — reporting volume, coverage, and product range all move the number. Always verify the individual notice with the issuing agency before acting on a specific product.
Blossom Pharmaceuticals: 13 federal recall notices aggregated from FDA, CPSC, USDA FSIS, and NHTSA filings (lead agency FDA Drug). Verify individual notices with FDA directly before acting on a specific recall.

Firm-level totals aggregate distinct federal recall events naming Blossom Pharmaceuticals; individual notices remain authoritative on each linked recall page.

Methodology · Corrections · FDA · CPSC · USDA FSIS · NHTSA · Archive as of September 2026